Brooke Gorham
Foot Surgery · Gadsden, ALNPI 1295907087
Payments from drug & device makers
What this record shows
This record is dominated by other: $205,900 of the $210,541 with a category attached, or 97.8%. Convatec Inc. accounts for 97.9% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $206,021, more than ten times the $138 reported in 2019. Among foot surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $1949.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$206K
- Triad Life Sciences Inc.$3K
- Stryker$642
- Paratek Pharmaceuticals, Inc.$216
- Aroa Biosurgery Incorporated$99
- Lifenet Health$96
- plus $622 from 18 others
What the payments were for
- Travel & lodging$2,5341%
- Food & beverage$2,1071%
- Other$205,90098%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 35 | $206,178 |
| Triad Life Sciences Inc. | 16 | $2,688 |
| Stryker | 9 | $642 |
| Paratek Pharmaceuticals, Inc. | 13 | $216 |
| Aroa Biosurgery Incorporated | 1 | $99 |
| Lifenet Health | 1 | $96 |
| KCI USA, Inc. | 5 | $90 |
| Johnson & Johnson | 2 | $56 |
| Smith+Nephew | 2 | $54 |
| GRT US Holding, Inc. | 3 | $45 |
| Kerecis Limited | 1 | $44 |
| Sanara Medtech Inc. | 3 | $39 |
| Integra Lifesciences Corporation | 3 | $38 |
| Averitas Pharma Inc. | 2 | $37 |
| Solventum Corporation | 2 | $36 |
| Nevro Corp. | 1 | $32 |
| Abbott | 2 | $30 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $14 |
| Innovation Technologies Inc | 1 | $14 |
| Merck | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$208,354
- ORTHOLOC 3DI$185
- EASYFUSE$133
How this compares
$210,541 in reported general payments places this provider in the 95th percentile of 35 foot surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 53 | $1,431 |
| Gabapentin | 67 | $1,208 |
| Terbinafine Hcl | 26 | $489 |
| Clotrimazole | 24 | $423 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $225 |
| Mupirocin | 18 | $139 |
| Methylprednisolone | 18 | $126 |
| Meloxicam | 28 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Gadsden
- John VanoreGadsden$17K
- Jean PrattGadsden$8K
- Michael ChmielewskiGadsden$100
- Eric FillingerCullman$19K
- Robert RussellBirmingham$7K
- Richard HarrisBirmingham$6K
- James BowmanSylacauga$4K
- Robson AraujoAlbertville$3K
- Stefan ZweigDothan$2K
- Michael McCollumMontgomery$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.